← Human Trials & Peer-Reviewed Studies
Simultaneous zinc and vitamin A supplementation in Bangladeshi children: randomised double blind controlled trial.
Plain-language guide to PMID 11498488 (2001): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 800 children.
Key Facts
- PMID
- 11498488
- Journal
- BMJ (Clinical research ed.)
- Year
- 2001
- Study type
- Randomized Controlled Trial
- Authors
- Rahman MM et al. (6 authors)
- DOI
- 10.1136/bmj.323.7308.314
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
To evaluate the effect of simultaneous zinc and vitamin A supplementation on diarrhoea and acute lower respiratory infections in children.
Who Took Part
The abstract describes 800 children taking part.
The age groups tagged for this paper are infants and young children, both men and women.
How the Study Was Run
The design is described as randomized, double-blind and placebo-controlled.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Blinding on both sides kept the children and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
Some children received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.
Randomised double blind placebo controlled trial.
Urban slums of Dhaka, Bangladesh.
What Was Measured
PubMed files the paper under topics including Acute Disease, Bangladesh, Diarrhea, Infantile, Dysentery, Morbidity, Poverty Areas and Respiratory Tract Infections.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 800 children.
With several hundred people or more, it is a fairly large study for this kind of research.
Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2001 (BMJ (Clinical research ed.)), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.